Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on ...
A line-up of experts across academia, pharma, and healthcare came together to discuss the impact and challenges of ...
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2024 on Wednesday, January 29, 2025 beginning at 8:00 a.m. ET and lasting ...
WASHINGTON, Jan. 2, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2024 on Wednesday, January 29 ...
An immunoassay is a test that relies on biochemistry to measure the presence and/or concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of ...
Bioconjugation Market Bioconjugation Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Bioconjugation Market by Product ...
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way ...
Dental Implants and Prosthesis Market. Dental Implants and Prosthesis companies are Fresenius SE & Co. KgaA, Boston Scientific, Cook Medical, Cardinal Heal ...
Check the time stamp on this data. Updated AI-Generated Signals for Danaher Corporation (DHR) available here: DHR.
Shares of Danaher Corp. DHR advanced 1.43% to $238.20 Monday, on what proved to be an all-around mixed trading session for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback